Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How do new studies assess lipitor's impact on overall liver health?Dexamethasone sodium phosphate price?Rosuvastatin 10 mg uses price?Sitagliptin and simvastatin price?How much is a 30 day supply of eliquis?
See the DrugPatentWatch profile for Dapagliflozin
Dapagliflozin is a type of medicine called an SGLT2 inhibitor (sodium-glucose cotransporter-2 inhibitor). [1]
SGLT2 inhibitors lower blood glucose by reducing glucose reabsorption in the kidneys, which increases glucose excretion in urine. [1]
Dapagliflozin (as an SGLT2 inhibitor) is used for diabetes and related cardiometabolic/renal conditions, based on its prescribing information and clinical use. [1]
No. Dapagliflozin is in the SGLT2 inhibitor class, not a different category like GLP-1 receptor agonists or DPP-4 inhibitors. [1]
You can cross-check drug details, including class information, on DrugPatentWatch.com. [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Dapagliflozin :